Further study utilizing selective and nonselective vasopressin agonists and antagonists could prove useful in characterizing the physiological changes produced by AVP, establishing the precise mechanisms by which AVP verses fructose contributes to renal disease, and identifying the utility of AVP receptor blockade to combat diseases such as Mesoamerican endemic nephropathy. Here, AVP is linked to kidney disorder.